Thrombopoietin Agonism to Promote Platelet Engraftment Following Hematopoietic Stem Cell Transplantation: Promising, but Not Ready for Primetime. | Transplant Cell Ther;30(5): 465-467, 2024 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Thrombopoietin Agonism to Promote Platelet Engraftment Following Hematopoietic Stem Cell Transplantation: Promising, but Not Ready for Primetime.

Al-Samkari, Hanny.

Affiliation

Al-Samkari H; Division of Hematology, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: hal-samkari@mgh.harvard.edu.

Transplant Cell Ther ; 30(5): 465-467, 2024 May.

Article in En | MEDLINE | ID: mdl-38677790

Subject(s)
Key words

hematopoietic stem cell transplantation; platelet engraftment; rhTPO; romiplostim; thrombopoietin

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombopoietin / Blood Platelets / Hematopoietic Stem Cell Transplantation Limits: Animals / Humans Language: En Journal: Transplant Cell Ther Year: 2024 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombopoietin / Blood Platelets / Hematopoietic Stem Cell Transplantation Limits: Animals / Humans Language: En Journal: Transplant Cell Ther Year: 2024 Document type: Article